Monoclonal Antibodies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibodies stocks.

Monoclonal Antibodies Stocks Recent News

Date Stock Title
Apr 25 REGN UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Apr 25 REGN Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Apr 25 XOMA XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
Apr 25 REGN Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Apr 25 REGN Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Apr 25 AZN US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
Apr 25 AZN Trending tickers: Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's
Apr 25 AZN AstraZeneca Earnings, Sales Rise, Beat Forecasts
Apr 25 REGN Regeneron expands in gene editing with Mammoth deal
Apr 25 AZN AstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlook
Apr 25 AZN UPDATE 2-AstraZeneca trounces first-quarter estimates as resilient demand fuels growth
Apr 25 AZN AstraZeneca leaps after smashing first-quarter forecasts
Apr 25 AZN Q1 2024 results
Apr 24 AZN Alphabet, Microsoft, Southwest earnings: What to watch
Apr 24 REGN Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Apr 24 ROIV Roivant Sciences: Cashing In On Vants And Ventures
Apr 24 AZN AstraZeneca Q1 2024 Earnings Preview
Apr 24 REGN Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Apr 24 MRUS Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Apr 24 HALO Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
Monoclonal Antibodies

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.

Browse All Tags